BLTE Belite Bio, Inc.

NASDAQ
$151.02

Belite Bio, Inc. (BLTE) Earnings News

Earnings press releases, previews and reviews for Belite Bio, Inc. (BLTE), newest first. Our most recent is review: Belite Bio Beats on the Bottom Line as FDA Path for Tinlarebant Clears, but Slipping GA Timelines and Rising Launch Spend Leave Investors Souring.